Projects per year
Personal profile
Fingerprint
Dive into the research topics where Francois Mullier is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The COVILAB project : Clinical laboratory investigations related to COVID-19
Douxfils, J. (Supervisor), Dogné, J.-M. (Co-supervisor), Favresse, J. (CoI), Tre-Hardy, M. (CoI), Mullier, F. (CoI), Haguet, H. (Researcher), Hardy, M. (Researcher), Melchionda, S. (Researcher), BOUVY, C. (Researcher), Morimont, L. (Researcher), Gillot, C. (Researcher), Djokoto, H. (Researcher), Alpan, L. (Technician), Devel, P. (Technician), Modaffari, E. (Technician) & Maloteau, V. (Technician)
13/03/20 → …
Project: Research
-
The DIT project : Drug induced thrombosis - a special focus on kinase and PARP inhibitors and
Douxfils, J. (Supervisor), Mullier, F. (Co-supervisor), Haguet, H. (Researcher) & RONVAUX, L. (Researcher)
1/09/15 → …
Project: Research
-
The BIOCOAG project : Biological assessment of the control of anticoagulation
Douxfils, J. (PI), Mullier, F. (CoI), Dogné, J.-M. (CoI), Siriez, R. (Researcher), Evrard, J. (Researcher) & Vassart, J. (Researcher)
1/09/11 → …
Project: Research
-
The MAS project : Measure And See the activity of direct oral anticoagulant in the clinical context
Douxfils, J. (Researcher) & Mullier, F. (CoI)
Project: Research
-
Assessment of frailty in older patients before cardiac surgery
de SAINT HUBERT, M. (PI), Gourdin, M. (PI), Michaux, I. (PI), TOUSSAINT, O. (PI), Caron, N. (PI) & Mullier, F. (PI)
1/04/12 → 31/12/13
Project: Research
-
Impact of asundexian on a panel of coagulation assays
Vassart, J., Ndzatou, D. B., Didembourg, M., Morimont, L., Brisbois, C., Jamart, L., Demeure, F., Lebreton, A., Mullier, F., Favresse, J., Hardy, M., Dogné, J.-M. & Douxfils, J., Jul 2025, In: Research and Practice in Thrombosis and Haemostasis. 9, 5, p. 102950 102950.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Downloads (Pure) -
Minimal Protamine Dosing during Drug Shortages: Comment
Hardy, M., Lasne, D., Gourdin, M., Lecompte, T., Gouin-Thibault, I. & Mullier, F., 1 Oct 2025, In: Anesthesiology. 143, 4, p. 1128-1130 3 p.Research output: Contribution to journal › Letter › peer-review
-
Preanalytical Conditions Impact Fibrin Monomers but Not D-Dimer: A Study With Rigorous Comparisons of a Broad Range of Simulated Conditions
Bouarroudj, H., Hardy, M., Lecompte, T. & Mullier, F., Apr 2025, In: International Journal of Laboratory Hematology. 47, 2, p. 330-335 6 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Revisiting the Environmental Impact of Inappropriate Clinical Laboratory Testing: A Comprehensive Overview of Sustainability, Economic, and Quality of Care Outcomes
Devis, L., Closset, M., Degosserie, J., Lessire, S., Modrie, P., Gruson, D., Favaloro, E. J., Lippi, G., Mullier, F. & Catry, E., 3 Jan 2025, In: The journal of applied laboratory medicine. 10, 1, p. 113-129 17 p.Research output: Contribution to journal › Review article › peer-review
-
Asundexian in atrial fibrillation: A predictable failure based on pharmacodynamic data?
Vassart, J., Didembourg, M., Morimont, L., Brisbois, C., Jamart, L., Lebreton, A., Mullier, F., Donis, N., Favresse, J., Dogné, J.-M. & Douxfils, J., 30 May 2024.Research output: Contribution to conference › Poster › peer-review
File13 Downloads (Pure)
Datasets
-
Clustering and kernel density estimation for assessment of measurable residual disease by flow cytometry
Jacqmin, H. (Contributor), Chatelain, B. (Contributor), Louveaux, Q. (Contributor), Jacqmin, P. (Contributor), Dogné, J.-M. (Contributor), Graux, C. (Contributor) & Mullier, F. (Contributor), Zenodo, 18 May 2020
Dataset
-
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), Chatelain, C. (Contributor), Mullier, F. (Contributor), Haguet, H. (Contributor), DOGNE, J.-M. (Contributor) & Douxfils, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
Prizes
-
Prix Léo Pharma Cancer & Thrombosis
Haguet, H. (Recipient), Douxfils, J. (Recipient), Mullier, F. (Recipient) & Dogne, J.-M. (Recipient), 25 Feb 2017
Prize: Prize (including medals and awards)
Activities
- 6 Oral presentation
-
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
21 Mar 2019Activity: Talk or presentation types › Oral presentation
-
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Haguet, H. (Speaker), Douxfils, J. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker), Mullier, F. (Speaker) & Dogne, J.-M. (Speaker)
9 Feb 2018Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
25 Feb 2017Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
28 Apr 2016Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
29 Jan 2016Activity: Talk or presentation types › Oral presentation
Thesis
-
Quantification and characterization of microvesicles: applications in hereditary spherocytosis, type-II heparin-induced thrombocytopenia and cancer
Mullier, F. (Author), Dogne, J.-M. (Supervisor), Masereel, B. (President), Chatelain, B. (Co-Supervisor), Michiels, C. (Jury), Latinne, D. (Jury), Chatelain, C. (Jury), Wallemacq, P. (Jury), Harrison, P. A. (Jury) & Hoylaerts, M. F. (Jury), 26 Mar 2012Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences
Press/Media
-
Catholic University Louvain (UCLouvain) Reports Findings in Sustainability Research (Revisiting the Environmental Impact of Inappropriate Clinical Laboratory Testing: A Comprehensive Overview of Sustainability, Economic, and Quality of Care ...)
Mullier, F., Closset, M., Catry, E. & Degosserie, J.
10/10/24
1 item of Media coverage
Press/Media: Expert Comment
-
Study Results from University of Namur Broaden Understanding of Coxsackievirus (Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome)
Dogné, J.-M., Douxfils, J., Mullier, F., Favresse, J. & Gillot, C.
10/01/23
1 item of Media coverage
Press/Media: Expert Comment
-
New Thrombosis Study Findings Recently Were Published by Researchers at Catholic University of Louvain (UCLouvain) (Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system)
28/12/22
1 item of Media coverage
Press/Media: Expert Comment
-
Reports from Namur Research Institute for Life Sciences (NARILIS) Add New Data to Research in Thrombosis and Haemostasis (Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban-treated patients and healthy ...)
Dogné, J.-M., Douxfils, J., Mullier, F., Siriez, R. & Favresse, J.
24/11/22
1 item of Media coverage
Press/Media: Expert Comment